1Ahren B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. Clin Endocrinol Metab, 2004, 89(5): 2078-2084
2Zimmet P,Shaw J, Albertit KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med, 2003, 20(9): 693-702
3Wiseman, Alexander, Ronald. Current status of clinical islet transplantation: advances and obstacles. Curr Opin Endocrinol Diabetes, 2004, 11(2): 98-103
4Zhang Y, Atkinson. Gene therapy for type 1 diabetes: metabolism, immunity, islet cell preservation, and regeneration. Curr Opin Endocrinol Diabetes, 2004, 11(2): 91-97
5Bloomgarden ZT. Type 2 diabetes in the young. Diabetes Care, 2004, 27(4): 998-1010
6Engelgau MM. Diabetes diagnostic criteria and impaired Glycemic states: evolving evidence base. Clin Diabetes, 2004, 22(2): 69-70
7Gura T. Diabetes research: new lead found to a possible ""insulin pill"". Science, 1999, 284(5416): 886
8Barnett AH. A review of basal insulins. Diabet Med, 2003, 20(11): 873-885
9Cefalu WT. Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care, 2004, 27(1): 239-246
2Heekim C, Yun S K, Byun D W, et al. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men [J ]. Diabetes, 2000,49(suppl 1) :A434.
3Georgopoulos A, Aras O, Tsai M Y. Interaction of type 2 diabetes with the codon 54 polymorphism of the fatty acid binding protein 2 gene leads to hypertriglyceridemia[J]. Diabetes,2000,49(suppl 1): 83.
4Kousta E, Huxtable S, Saker P, et al. Sulfonylurea receptor-1 gene variants show no association with type 2 diabetes in north European populations when analysed using family-based association methods [J].Diabetes, 2000,40 (suppl 1): A203.
5Ji L N, Luo Y Q, Han X Y, et al. Sulfonylurea receptor-1 gene polymorphism is associated with high insulin secretion levels in non-diabetic Chinese [J].Diabetes, 2000,40(suppl 1):A398.
6Gambino V, Menzel S, Trabb J B. An approach for identifying simple sequence repeat DNA polymorphisms near cloned cDNAs and genes. Linkage studies of the islet amyloid polypeptide/amylin and liver glycogen synthase genes and NIDDM [J].Diabetes,1996,45: 291-294.
7Soeller W C, Janson J, Hart S E, et al. Islet amyloid-associated diabetes in obese A (VY)/a mic expressing human islet amyloid polypeptide [J ]. Diabetes, 1998, 47:743-750.
8Kahn S E, Andrikopoulos S, Verchere C B, et al.Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans[J]. Diabetes, 1998,47:640-645.
9Ishiyamy-Shigemoto S, Yamata K, Yuan X, et al.Association of polymorphism in the β2-adrenergic receptor gene with obesity, hypertriglyceridemia and diabetes mellitus[J]. Diabetologia, 1999,42:98-101.
10Klannemark M, Orho M, Langin D, et al. The putative role of the hormone sensitive lipase gene in the pathogenesis of Type Ⅱ diabetes mellitus and abdominal obesity[J]. Diabetologia, 1998, 41:1516-1522.
